highperformr logo

Novartis's Overview

Total employees79028
HeadquartersBasel
Founded

Novartis is a global healthcare company headquartered in Basel, Switzerland, focused on reimagining medicine to improve and extend people's lives. Leveraging innovative science and digital technologies, Novartis creates transformative treatments in areas of high unmet medical need. The company's portfolio includes innovative medicines across various therapeutic areas, including oncology, immunology, neuroscience, cardiovascular, and respiratory diseases. Novartis is committed to research and development, aiming to deliver breakthrough therapies that address some of society's most challenging healthcare issues.

Where is Novartis's Headquarters?

HQ Function

The Novartis global headquarters serves as the central hub for strategic decision-making, corporate governance, global research and development leadership, and core corporate functions.

Notable Features:

The Novartis Campus in Basel is renowned for its modern architecture, designed by world-class architects, featuring state-of-the-art research laboratories, collaborative office spaces, and sustainable green areas. It's often referred to as a 'city of knowledge'.

Work Culture:

The work culture at the Novartis HQ emphasizes innovation, collaboration, scientific excellence, and a 'curious, inspired, and unbossed' mindset. It fosters a diverse and inclusive environment dedicated to advancing healthcare.

HQ Significance:

Basel's strategic location in the heart of Europe, with a rich history in pharmaceuticals and life sciences, provides Novartis with access to top talent, research institutions, and a strong industry network.

Values Reflected in HQ: The campus architecture and environment reflect Novartis's core values of innovation, collaboration, integrity, courage, and quality.

Location:

Novartis maintains a significant global footprint, with operations in approximately 140 countries worldwide. Key functions supported globally include research and development (with major research centers in Switzerland, the US, and China), manufacturing (with a network of production sites), and commercial operations tailored to local market needs. This widespread presence enables Novartis to conduct global clinical trials, access diverse scientific talent, and deliver its innovative medicines to patients across the globe.

Street Address:

Lichtstrasse 35

City:

Basel

State/Province:

Basel-Stadt

Country:

Switzerland

Novartis's Global Presence

East Hanover, New Jersey, USA

Address: One Health Plaza, East Hanover, NJ 07936-1080, USA

Critical for managing Novartis's activities in the largest pharmaceutical market globally, including bringing innovative medicines to American patients, conducting clinical trials, and engaging with regulatory authorities like the FDA.

Dublin, Ireland

Address: Elm Park, Merrion Road, Dublin 4, Ireland

Acts as a key strategic hub for global operations, leveraging Ireland's skilled workforce and business environment to support Novartis's worldwide activities and supply chain.

Hyderabad, India

Address: Novartis Healthcare Pvt. Ltd., NSL SEZ (Arena), Plot No 6, Survey No 1, IDA Uppal, Hyderabad, Telangana 500039, India

Leverages India's talent pool to provide critical support for Novartis's global R&D and commercial operations, contributing to efficiency and innovation across the company.

Buying Intent Signals for Novartis

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Novartis

As of April 2025, Novartis' leadership includes:

Vasant (Vas) Narasimhan, M.D. - Chief Executive Officer (CEO)
Harry Kirsch - Chief Financial Officer (CFO) (until August 31, 2024)
Shreeram Aradhye, M.D. - President, Global Drug Development and Chief Medical Officer (Incoming CFO effective September 1, 2024)
Fiona H. Marshall, Ph.D. - President, Novartis Institutes for BioMedical Research (NIBR)
Marie-France Tschudin - President, Innovative Medicines International and Chief Commercial Officer
Victor Bulto - President, Innovative Medicines US
Karen L. Hale - Chief Legal Officer
Rob Kowalski, Ph.D. - Chief People & Organization Officer

Investors of Novartis

Novartis has been backed by several prominent investors over the years, including:

Novartis is a publicly traded company on the SIX Swiss Exchange (NOVN) and the New York Stock Exchange (NVS).
Major institutional investors include firms like BlackRock, The Vanguard Group, Capital Group Companies, and Norges Bank Investment Management.
A significant portion of shares is also held by private investors and through American Depositary Receipts (ADRs).

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits2

Novartis has experienced notable executive transitions in the past 12 months, including the announcement of a new Chief Financial Officer, a new Chief Strategy & Growth Officer, and changes in operations leadership, reflecting its ongoing strategic evolution.

Departures

Harry Kirsch, Announced retirement effective August 31, 2024, after more than a decade as CFO.
Steffen Lang, Ph.D., Departed from the role of President, Operations.

New Appointments:

Robert Weltevreden, Appointed to lead Customer & Technology Solutions and as Country President for Switzerland.
Shreeram Aradhye, M.D., Appointed as new CFO, transitioning from Chief Medical Officer and Head of Global Drug Development.
Ronny Gal, Ph.D., Appointed as new Chief Strategy & Growth Officer.

Technology (Tech Stack) used by Novartis

Discover the tools Novartis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Novartis Email Formats and Examples

Novartis commonly uses the firstname.lastname@novartis.com email format for its employees. While variations may exist for specific departments or legacy systems, this is the most prevalent structure.

firstname.lastname@novartis.com

Format

jane.doe@novartis.com

Example

90%

Success rate

News and media

Novartis Press ReleaseMay 23, 2024

Novartis Pluvicto™ significantly improved radiographic progression-free survival in PSMA-positive metastatic castration-resistant prostate cancer in pre-taxane setting

Novartis announced positive results from the Phase III PSMAfore trial, where Pluvicto™ showed a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) in patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) after treatment with an androgen receptor pathway inhibitor (ARPI), prior to receiving taxane-based chemotherapy....more

Novartis Press ReleaseApril 23, 2024

Novartis delivers strong Q1 sales and core operating income growth, raises full-year 2024 guidance

Novartis announced strong Q1 2024 results with net sales growing 10% (cc, USD) and core operating income up 20% (cc, USD). The company raised its full-year 2024 guidance for both net sales and core operating income, reflecting continued strong performance across key growth drivers....more

Novartis Press ReleaseApril 16, 2024

Novartis completes acquisition of MorphoSys AG, strengthening oncology pipeline

Novartis announced the successful completion of its voluntary public takeover offer for MorphoSys AG, a biopharmaceutical company developing innovative cancer treatments. The acquisition strengthens Novartis's oncology pipeline, adding pelabresib, a late-stage BET inhibitor for myelofibrosis, and tulmimetostat, an early-stage dual inhibitor of EZH2 and EZH1 for solid tumors or lymphomas....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Novartis, are just a search away.